CoChat

Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis

Open access

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

Abstract

The transforming growth factor-β (TGF-β) signalling pathway is a key mediator of fibroblast activation that drives the aberrant synthesis of extracellular matrix in fibrotic diseases. Here we demonstrate a novel link between transforming growth factor-β and the canonical Wnt pathway. TGF-β stimulates canonical Wnt signalling in a p38-dependent manner by decreasing the expression of the Wnt antagonist Dickkopf-1. Tissue samples from human fibrotic diseases show enhanced expression of Wnt proteins and decreased expression of Dickkopf-1. Activation of the canonical Wnt pathway stimulates fibroblasts in vitro and induces fibrosis in vivo. Transgenic overexpression of Dickkopf-1 ameliorates skin fibrosis induced by constitutively active TGF-β receptor type I signalling and also prevents fibrosis in other TGF-β-dependent animal models. These findings demonstrate that canonical Wnt signalling is necessary for TGF-β-mediated fibrosis and highlight a key role for the interaction of both pathways in the pathogenesis of fibrotic diseases. Aberrant activation of the TGF-β pathway leads to fibrotic disease. Distler and colleagues show that TGF-β-mediated fibrosis requires the decrease of Dickkopf-1, an antagonist of canonical Wnt signalling, suggesting that the two pathways interact for the manifestation of this disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms1734

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Canonical Wnt signalling is activated in fibrotic diseases. (a) β-catenin, the central signalling component of the canonical Wnt pathway, accumulated in the nuclei of fibroblasts in samples from patients with SSc (n=12 for SSc and n=10 for normal skin), IPF (n=8 for IPF and n=6 for non-fibrotic lung) and liver cirrhosis (n=6 for liver cirrhosis and n=6 for non-fibrotic liver). Nuclear accumulation of β-catenin in dermal fibroblasts was also observed in the experimental models of bleomycin-induced dermal fibrosis and in Tsk-1 mice (n=10 each). A minimum of 100 nuclei per sample was counted. (b) The mRNA levels of the Wnt target gene axin-2 were significantly increased in systemic sclerosis patients, bleomycin challenged mice and Tsk-1 mice (n=8 each). * Indicates P-values of less than 0.05 (analysed using the Mann–Whitney U-test) as compared with healthy volunteers or with non-fibrotic control mice, respectively. All data are expressed as mean ± s.e.m.
Figure 1 Canonical Wnt signalling is activated in fibrotic diseases. (a) β-catenin, the central signalling component of the canonical Wnt pathway, accumulated in the nuclei of fibroblasts in samples from patients with SSc (n=12 for SSc and n=10 for normal skin), IPF (n=8 for IPF and n=6 for non-fibrotic lung) and liver cirrhosis (n=6 for liver cirrhosis and n=6 for non-fibrotic liver). Nuclear accumulation of β-catenin in dermal fibroblasts was also observed in the experimental models of bleomycin-induced dermal fibrosis and in Tsk-1 mice (n=10 each). A minimum of 100 nuclei per sample was counted. (b) The mRNA levels of the Wnt target gene axin-2 were significantly increased in systemic sclerosis patients, bleomycin challenged mice and Tsk-1 mice (n=8 each). * Indicates P-values of less than 0.05 (analysed using the Mann–Whitney U-test) as compared with healthy volunteers or with non-fibrotic control mice, respectively. All data are expressed as mean ± s.e.m.CC BY-NC-ND · PubMed Central
Figure 2 Wnt-1 and Wnt-10b are upregulated in fibrotic diseases and Dkk-1 is downregulated. (a) Confocal microscopy with double staining for Wnt-1 and vimentin demonstrated an overexpression of Wnt-1, in particular, in vimentin-positive cells in fibrotic skin of patients with SSc, in IPF and in liver cirrhosis. (b) Wnt-10b was also overexpressed in SSc, IPF and liver cirrhosis. (c) In parallel to the upregulation of Wnt-1 and Wnt-10b, a prominent decrease of the endogenous antagonist Dkk-1 was observed in fibroblasts in fibrotic diseases. Representative examples from 12 patients with SSc, 10 samples of non-fibrotic skin, 10 patients with IPF, 6 control lungs, 8 patients with liver cirrhosis and 8 control livers are shown. Scale bars, 20 or 5 μm for the outer right image of each panel, respectively.
Figure 2 Wnt-1 and Wnt-10b are upregulated in fibrotic diseases and Dkk-1 is downregulated. (a) Confocal microscopy with double staining for Wnt-1 and vimentin demonstrated an overexpression of Wnt-1, in particular, in vimentin-positive cells in fibrotic skin of patients with SSc, in IPF and in liver cirrhosis. (b) Wnt-10b was also overexpressed in SSc, IPF and liver cirrhosis. (c) In parallel to the upregulation of Wnt-1 and Wnt-10b, a prominent decrease of the endogenous antagonist Dkk-1 was observed in fibroblasts in fibrotic diseases. Representative examples from 12 patients with SSc, 10 samples of non-fibrotic skin, 10 patients with IPF, 6 control lungs, 8 patients with liver cirrhosis and 8 control livers are shown. Scale bars, 20 or 5 μm for the outer right image of each panel, respectively.CC BY-NC-ND · PubMed Central
Figure 3 Activation of the canonical Wnt pathway induces fibrosis. (a) Recombinant Wnt-1 stimulated the activity of col1a2 promoter constructs (n=6). (b) Incubation with recombinant Wnt-1 increased the release of collagen protein by cultured fibroblasts in a dose-dependent manner (n=6). (c) Wnt-1 induced the expression of αSMA protein (n=5). (d) Incubation with Wnt-1 increased the mRNA levels of αSMA (n=5). (e) Wnt-1 stimulated the formation of stress fibres in cultured fibroblasts (n=6). Of note, the stimulatory effects of Wnt-1 on fibroblasts were comparable with those of TGF-β. (f) Transgenic overexpression of Wnt-10b induced dermal fibrosis in mice. The dermal thickness, the hydroxyproline content and the numbers of myofibroblasts were already increased in Wnt-10b tg mice at an age of 3 weeks and increased further with age (n ≥ 5 for all groups). Representative haematoxylin and eosin-, trichrome- and Sirius Red-stained sections of wild-type (WT) and Wnt-10b transgenic (Wnt-10b tg) mice at ages of 3, 6 and 12 weeks are shown (horizontal scale bars, 100 μm). Black vertical bars indicate the dermal thickness. * Indicates P-values of less than 0.05 as compared with mock-treated fibroblasts (a–e, analysed with the Wilcoxon signed-rank test) or compared with wild-type littermates (f, analysed using the Mann–Whitney U-test), respectively. All data are expressed as mean ± s.e.m.
Figure 3 Activation of the canonical Wnt pathway induces fibrosis. (a) Recombinant Wnt-1 stimulated the activity of col1a2 promoter constructs (n=6). (b) Incubation with recombinant Wnt-1 increased the release of collagen protein by cultured fibroblasts in a dose-dependent manner (n=6). (c) Wnt-1 induced the expression of αSMA protein (n=5). (d) Incubation with Wnt-1 increased the mRNA levels of αSMA (n=5). (e) Wnt-1 stimulated the formation of stress fibres in cultured fibroblasts (n=6). Of note, the stimulatory effects of Wnt-1 on fibroblasts were comparable with those of TGF-β. (f) Transgenic overexpression of Wnt-10b induced dermal fibrosis in mice. The dermal thickness, the hydroxyproline content and the numbers of myofibroblasts were already increased in Wnt-10b tg mice at an age of 3 weeks and increased further with age (n ≥ 5 for all groups). Representative haematoxylin and eosin-, trichrome- and Sirius Red-stained sections of wild-type (WT) and Wnt-10b transgenic (Wnt-10b tg) mice at ages of 3, 6 and 12 weeks are shown (horizontal scale bars, 100 μm). Black vertical bars indicate the dermal thickness. * Indicates P-values of less than 0.05 as compared with mock-treated fibroblasts (a–e, analysed with the Wilcoxon signed-rank test) or compared with wild-type littermates (f, analysed using the Mann–Whitney U-test), respectively. All data are expressed as mean ± s.e.m.CC BY-NC-ND · PubMed Central
Figure 4 Inhibition of canonical Wnt signalling by Dkk-1 prevents experimental fibrosis. (a) Dkk-1 transgenic (Dkk-1 tg) mice were resistant to bleomycin-induced fibrosis. Haematoxylin and eosin-, Sirius Red- and trichrome-stained sections are shown (horizontal scale bars, 100 μm). Challenge with bleomycin induced dermal fibrosis with increased dermal thickening, accumulation of hydroxyproline and myofibroblast differentiation in wild-type mice, but not in Dkk-1 tg littermates. In contrast to wild-type mice, these outcomes did not differ between Dkk-1 tg mice challenged with bleomycin and Dkk-1 tg mice injected with NaCl (n ≥ 6 for all groups). (b) Dkk-1 prevented fibrosis in Tsk-1 mice. The histological changes induced by the Tsk-1 mutation in the fibrillin-1 gene are ameliorated by transgenic overexpression of Dkk-1, as shown in representative haematoxylin and eosin-, Sirius Red- and trichrome-stained sections (horizontal scale bars, 200 μm). Hypodermal thickening, hydroxyproline content and myofibroblast counts were all significantly reduced in Tsk-1/Dkk-1, as compared with Tsk-1 littermates not carrying the Dkk-1 transgene (n ≥ 5 for all groups). Vertical black bars in these images indicate the dermal or hypodermal thickness. *Indicates P-values of less than 0.05 as compared with wild-type mice challenged with bleomycin (a) and with Tsk-1 mice not transgenic for Dkk-1 (b), respectively, as analysed using the Mann–Whitney U-test. All data are expressed as mean ± s.e.m.
Figure 4 Inhibition of canonical Wnt signalling by Dkk-1 prevents experimental fibrosis. (a) Dkk-1 transgenic (Dkk-1 tg) mice were resistant to bleomycin-induced fibrosis. Haematoxylin and eosin-, Sirius Red- and trichrome-stained sections are shown (horizontal scale bars, 100 μm). Challenge with bleomycin induced dermal fibrosis with increased dermal thickening, accumulation of hydroxyproline and myofibroblast differentiation in wild-type mice, but not in Dkk-1 tg littermates. In contrast to wild-type mice, these outcomes did not differ between Dkk-1 tg mice challenged with bleomycin and Dkk-1 tg mice injected with NaCl (n ≥ 6 for all groups). (b) Dkk-1 prevented fibrosis in Tsk-1 mice. The histological changes induced by the Tsk-1 mutation in the fibrillin-1 gene are ameliorated by transgenic overexpression of Dkk-1, as shown in representative haematoxylin and eosin-, Sirius Red- and trichrome-stained sections (horizontal scale bars, 200 μm). Hypodermal thickening, hydroxyproline content and myofibroblast counts were all significantly reduced in Tsk-1/Dkk-1, as compared with Tsk-1 littermates not carrying the Dkk-1 transgene (n ≥ 5 for all groups). Vertical black bars in these images indicate the dermal or hypodermal thickness. *Indicates P-values of less than 0.05 as compared with wild-type mice challenged with bleomycin (a) and with Tsk-1 mice not transgenic for Dkk-1 (b), respectively, as analysed using the Mann–Whitney U-test. All data are expressed as mean ± s.e.m.CC BY-NC-ND · PubMed Central
Figure 5 TGF-β activates canonical Wnt signalling by decreasing Dkk-1. (a) TGF-β induces nuclear accumulation of β-catenin in cultured human fibroblasts as shown by Western blot from cytoplasmic and nuclear extracts (n=4). (b) TGF-β stimulates the activity of a TCF/Lef reporter construct (n=8). (c) Adenoviral overexpression of TBRIact in the skin of mice (Ad-TBRI) induced nuclear accumulation of β-catenin in fibroblasts as compared with control mice infected with adenovirus encoding for LacZ (Ad-LacZ) (n ≥ 6). (d) Ad-TBRI uprgeulated the mRNA levels of the Wnt target gene axin-2 (n ≥ 6). (e) Incubation with TGF-β reduced the mRNA levels of Dkk-1 in cultured fibroblasts (n=7). (f) TGF-β decreased the protein levels of Dkk-1 in cultured fibroblasts (n=5). (g) Decreased levels of Dkk-1 were also observed in the skin of Ad-TBRI mice by western blot (n=4). Representative bands and the mean results of the densiometric quantification are shown in a, f and g. * Indicates P-values of less than 0.05 as compared with unstimulated cells (a, b, e and f, as analysed with the Wilcoxon signed-rank test) and with Ad-LacZ mice (c, d and g, as analysed using the Mann–Whitney U-test). All data are expressed as mean ± s.e.m.
Figure 5 TGF-β activates canonical Wnt signalling by decreasing Dkk-1. (a) TGF-β induces nuclear accumulation of β-catenin in cultured human fibroblasts as shown by Western blot from cytoplasmic and nuclear extracts (n=4). (b) TGF-β stimulates the activity of a TCF/Lef reporter construct (n=8). (c) Adenoviral overexpression of TBRIact in the skin of mice (Ad-TBRI) induced nuclear accumulation of β-catenin in fibroblasts as compared with control mice infected with adenovirus encoding for LacZ (Ad-LacZ) (n ≥ 6). (d) Ad-TBRI uprgeulated the mRNA levels of the Wnt target gene axin-2 (n ≥ 6). (e) Incubation with TGF-β reduced the mRNA levels of Dkk-1 in cultured fibroblasts (n=7). (f) TGF-β decreased the protein levels of Dkk-1 in cultured fibroblasts (n=5). (g) Decreased levels of Dkk-1 were also observed in the skin of Ad-TBRI mice by western blot (n=4). Representative bands and the mean results of the densiometric quantification are shown in a, f and g. * Indicates P-values of less than 0.05 as compared with unstimulated cells (a, b, e and f, as analysed with the Wilcoxon signed-rank test) and with Ad-LacZ mice (c, d and g, as analysed using the Mann–Whitney U-test). All data are expressed as mean ± s.e.m.CC BY-NC-ND · PubMed Central
Figure 6 Dkk-1 prevented the stimulatory effects of TGF-β on canonical Wnt signalling. (a) Recombinant Dkk-1 abrogated the TGF-β induced nuclear accumulation of β-catenin as assessed by immunofluorescence (n=6). (b) The inhibitory effects of Dkk-1 on the TGF-β-induced nuclear accumulation of β-catenin were confirmed by western blot (n=4). (c) Dkk-1 prevented the TGF-β-induced activation of a TCF/Lef reporter construct in vitro. Recombinant Wnt-1 was used as a positive control (n=8). (d) Nuclear accumulation of β-catenin was observed in wild-type mice infected with adenovirus encoding for TBRIact (Ad-TBR), but not in Dkk-1 transgenic mice (Dkk-1 tg; n ≥ 5 for all groups). (e) Ad-TBRI increased the mRNA levels of axin-2 in wild-type mice, but not Dkk-1 tg mice (n ≥ 5 for all groups). * Indicates P-values of less than 0.05 as compared with cells stimulated with TGF-β (b,c) or with wild-type mice infected with Ad-TBRI (d,e). All results were analysed using the Wilcoxon signed-rank test. All data are expressed as mean ± s.e.m.
Figure 6 Dkk-1 prevented the stimulatory effects of TGF-β on canonical Wnt signalling. (a) Recombinant Dkk-1 abrogated the TGF-β induced nuclear accumulation of β-catenin as assessed by immunofluorescence (n=6). (b) The inhibitory effects of Dkk-1 on the TGF-β-induced nuclear accumulation of β-catenin were confirmed by western blot (n=4). (c) Dkk-1 prevented the TGF-β-induced activation of a TCF/Lef reporter construct in vitro. Recombinant Wnt-1 was used as a positive control (n=8). (d) Nuclear accumulation of β-catenin was observed in wild-type mice infected with adenovirus encoding for TBRIact (Ad-TBR), but not in Dkk-1 transgenic mice (Dkk-1 tg; n ≥ 5 for all groups). (e) Ad-TBRI increased the mRNA levels of axin-2 in wild-type mice, but not Dkk-1 tg mice (n ≥ 5 for all groups). * Indicates P-values of less than 0.05 as compared with cells stimulated with TGF-β (b,c) or with wild-type mice infected with Ad-TBRI (d,e). All results were analysed using the Wilcoxon signed-rank test. All data are expressed as mean ± s.e.m.CC BY-NC-ND · PubMed Central
Figure 7 Inhibition of TGF-β signalling reduces the activation of canonical Wnt in experimental fibrosis. (a) Treatment with SD-208, a selective inhibitor of TBRI, significantly decreased the nuclear accumulation of β-catenin in fibroblasts in bleomycin-induced dermal fibrosis, in Tsk-1 mice and in TBRIact induced fibrosis (n ≥ 5 for all groups in all models). (b) SD-208 completely prevented the increase in the mRNA levels of axin-2 in these mouse models (n ≥ 5 for all groups in all models). * Indicates P-values of less than 0.05 (as analysed with the Mann–Whitney U-test) compared with bleomycin treated-, Tsk-1, or TBRIact mice without SD-208. All data are expressed as mean ± s.e.m.
Figure 7 Inhibition of TGF-β signalling reduces the activation of canonical Wnt in experimental fibrosis. (a) Treatment with SD-208, a selective inhibitor of TBRI, significantly decreased the nuclear accumulation of β-catenin in fibroblasts in bleomycin-induced dermal fibrosis, in Tsk-1 mice and in TBRIact induced fibrosis (n ≥ 5 for all groups in all models). (b) SD-208 completely prevented the increase in the mRNA levels of axin-2 in these mouse models (n ≥ 5 for all groups in all models). * Indicates P-values of less than 0.05 (as analysed with the Mann–Whitney U-test) compared with bleomycin treated-, Tsk-1, or TBRIact mice without SD-208. All data are expressed as mean ± s.e.m.CC BY-NC-ND · PubMed Central
Figure 8 Inhibition of canonical Wnt signalling by Dkk-1 prevents Ad-TBRIact-induced fibrosis. Intradermal infection with adenoviruses encoding for TBRIact (Ad-TBRI) induced dermal fibrosis in wild-type mice, but not in Dkk-1 transgenic (Dkk-1 tg) littermates. Representative histological sections stained with haematoxylin and eosin, Sirius Red and trichrome are shown (horizontal scale bar, 100 μm). The dermal thickening observed in wild-type mice on infection with Ad-TBRI was significantly ameliorated in Dkk-1 transgenic (Dkk-1 tg) mice. The Ad-TBRI-mediated increases in hydroxyproline content and in the number of myofibroblasts were also reduced in Dkk-1 tg mice (n ≥ 5 for all groups). * Indicates P-values of less than 0.05 (as analysed using the Mann–Whitney U-test) compared with wild-type mice infected with Ad-TBRI. All data are expressed as mean ± s.e.m.
Figure 8 Inhibition of canonical Wnt signalling by Dkk-1 prevents Ad-TBRIact-induced fibrosis. Intradermal infection with adenoviruses encoding for TBRIact (Ad-TBRI) induced dermal fibrosis in wild-type mice, but not in Dkk-1 transgenic (Dkk-1 tg) littermates. Representative histological sections stained with haematoxylin and eosin, Sirius Red and trichrome are shown (horizontal scale bar, 100 μm). The dermal thickening observed in wild-type mice on infection with Ad-TBRI was significantly ameliorated in Dkk-1 transgenic (Dkk-1 tg) mice. The Ad-TBRI-mediated increases in hydroxyproline content and in the number of myofibroblasts were also reduced in Dkk-1 tg mice (n ≥ 5 for all groups). * Indicates P-values of less than 0.05 (as analysed using the Mann–Whitney U-test) compared with wild-type mice infected with Ad-TBRI. All data are expressed as mean ± s.e.m.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 61 references

Cited by

Items 501–600 of 873

Metadata

Authors
Akhmetshina, A., Palumbo, K., Dees, C., Bergmann, C., Venalis, P., Zerr, P., Horn, A., Kireva, T., Beyer, C., Zwerina, J., Schneider, H., Sadowski, A., Riener, M.-O., MacDougald, O. A., Distler, O., Schett, G., & Distler, J. H. W.
Affiliations
  • Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
  • University of Michigan (US)
  • University Hospital Zurich (CH)
Corresponding author
Distler, Jörg H.W.
Venue
Nature Communications
Published
2012-03-13
Volume
3
Issue
1
Pages
735-735
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2059114286
Cited by
843
References
61
Citations by year
2026: 45 · 2025: 61 · 2024: 68 · 2023: 57 · 2022: 74 · 2021: 58 · 2020: 67 · 2019: 60 · 2018: 59 · 2017: 65 · 2016: 59 · 2015: 54 · 2014: 57 · 2013: 43 · 2012: 16
FWCI
21.84
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
  • RePEc: Research Papers in Economics (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • Bundesministerium für Bildung und Forschung (01EC1002D)
  • National Institutes of Health (DK62876)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R24DK092759, DK-51563, N02 DK062876, DK92759, R01DK051563, R01DK062876, P30DK020572)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords
Wnt/β-catenin signaling, TGF-beta signaling, fibrosis, DKK1, p38 MAPK, fibroblast activation, skin fibrosis, TGF-beta type I receptor, extracellular matrix synthesis, fibrotic diseases, pathway interactions
MeSH terms
Adult, Animals, Cells, Cultured, Extracellular Matrix, Female, Fibrosis, Humans, Male, Mice, Transgenic, Middle Aged, Transforming Growth Factor beta, Receptors, Transforming Growth Factor beta, RNA Interference, RNA, Small Interfering, Intercellular Signaling Peptides and Proteins, p38 Mitogen-Activated Protein Kinases, Wnt Proteins, Mice, Wnt Signaling Pathway

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.